As CEO and Co-Founder of Electron Bio, I lead our mission to revolutionize biomanufacturing by addressing the industry’s most pressing challenges—reducing costs, minimizing manufacturing issues, and consistently delivering high-quality therapies to patients. With over 25 years of experience at industry leaders such as Moderna, Eli Lilly, and Merck, my career has been dedicated to advancing bioprocess development, vaccine innovation, commercialization, and biomanufacturing.𝗣𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹 𝗠𝗶𝘀𝘀𝗶𝗼𝗻:I am driven by the ambition to streamline the path from laboratory research to market, ensuring that groundbreaking therapies are not just developed but also made accessible globally at an accelerated pace and affordable cost. This vision has guided my leadership across all facets of bioprocess development, from RNA therapeutics to DNA vaccines, yielding innovations that have profound implications for patient care worldwide.𝗟𝗲𝗮𝗱𝗲𝗿𝘀𝗵𝗶𝗽 𝗔𝗽𝗽𝗿𝗼𝗮𝗰𝗵:My leadership tenure, managing teams upwards of 100 professionals and steering high-stakes projects, has been characterized by a commitment to mentorship, collaborative problem-solving, and operational excellence. By fostering environments where innovation thrives, I’ve led teams to execute ambitious projects, delivering solutions that bridge the gap between science and global health needs.𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀 𝗼𝗳 𝗠𝘆 𝗖𝗮𝗿𝗲𝗲𝗿: • At Moderna, I led the DNA, enzymes, and chemical products division, playing a pivotal role in the strategic realignment essential for the production and global distribution of COVID-19 vaccines. • My work at Eli Lilly and Elanco involved driving biotechnology product modernization, enhancing portfolios, and significantly contributing to the companies’ revenue through strategic initiatives. • At Merck, I was at the forefront of RNA formulation and delivery as well as DNA and viral vaccines, contributing to advancements in vaccine technology.𝗙𝗼𝗿𝘄𝗮𝗿𝗱 𝗣𝗮𝘁𝗵: At Electron Bio, we are committed to solving manufacturing bottlenecks while ensuring that advanced therapies reach the patients who need them, faster and more efficiently than ever before. My passion lies in bridging the gap between groundbreaking research and tangible patient benefits, aiming to contribute to a future where healthcare solutions are readily available to those in need.